A synthetic peptide for use as a blocking control in assays to test for specificity of CLEC4 M antibody, Alternative Names: CLEC4M control peptide, CLEC4M antibody Blocking Peptide, Anti-CLEC4M Blocking Peptide, C-type lectin domain family 4, member M Blocking Peptide, CD299 Blocking Peptide, LSIGN Blocking Peptide, CD209L Blocking Peptide, L-SIGN Blocking Peptide, DCSIGNR Blocking Peptide, HP10347 Blocking Peptide, DC-SIGN2 Blocking Peptide, DC-SIGNR Blocking Peptide, MGC47866 Blocking Peptide, MGC129964 Blocking Peptide, CLEC4M Blocking Peptide, CLEC4M, CLECM-4, CLECM 4, CLECM-4 Blocking Peptide, CLECM 4 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
C-Type Lectin Domain Family 4, Member M (CLEC4M)
Hintergrund
CLEC4M is a transmembrane receptor and is often referred to as L-SIGN because of its expression in the endothelial cells of the lymph nodes and liver. It is involved in the innate immune system and recognizes numerous evolutionarily divergent pathogens ranging from parasites to viruses, with a large impact on public health.